wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34788381-7D1E0AC6-AA42-4E7B-A7AE-CF865BA95557
Q34788381-7D1E0AC6-AA42-4E7B-A7AE-CF865BA95557
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34788381-7D1E0AC6-AA42-4E7B-A7AE-CF865BA95557
Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.
P2860
Q34788381-7D1E0AC6-AA42-4E7B-A7AE-CF865BA95557
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34788381-7D1E0AC6-AA42-4E7B-A7AE-CF865BA95557
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be5785cf000da412af12f9d614db0992be06798d
P2860
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.